GSK-A1
GSK-A1 is a potent and selective PI4KA inhibitor that suppresses calcium-induced prolactin secretion without impacting calcium signaling or Prl gene expression. Its inhibition of the host PI4KA enzyme also confers promising anti-HCV activity, making it a valuable tool for studying phosphatidylinositol signaling and viral replication in vitro.
Product Specifications
CAS Number
1416334-69-4
Product Name Alternative
Inhibit, Hepatitis C virus, HCVProtease, HCV Protease, HCV, Inhibitor, GSK A1, GSKA1, GSK-A1, GSK-A-1, PI4KIIIα, PI4K, PI4 kinases, Phosphatidylinositol 4 kinases, phosphatidylinositol 4-kinase PI4KA, PtdIns (4) P, PtdIns (4,5) P2
Field of Research
Infectious Disease & Virology, Protein Biochemistry, Signal Transduction
Purity
97.97% (May vary between batches)
Solubility
DMSO:2.3 mg/mL (4 mM)
Smiles
COc1ncc (cc1S (=O) (=O) Nc1ccccc1F) -c1ccc2nc (N) n (-c3ccc (cc3) N3CCOCC3) c2c1
Molecular Formula
C29H27FN6O4S
Molecular Weight
574.63
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
